Literature DB >> 24978382

Serum levels of soluble urokinase plasminogen activator receptor in Japanese patients with chronic kidney disease.

Yoshinori Taniguchi1, Yoshiko Shimamura1, Taro Horino1, Shimpei Fujimoto1, Yoshio Terada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24978382     DOI： 10.1038/ki.2014.136

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  5 in total

1.  Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design.

Authors:  Matthew Schenk; Fabian Eichelmann; Matthias B Schulze; Natalia Rudovich; Andreas F Pfeiffer; Romina di Giuseppe; Heiner Boeing; Krasimira Aleksandrova
Journal:  Biomark Med       Date:  2019-06-03       Impact factor: 2.851

2.  Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis.

Authors:  Jiwon M Lee; Jae Won Yang; Andreas Kronbichler; Michael Eisenhut; Gaeun Kim; Keum Hwa Lee; Jae Il Shin
Journal:  J Immunol Res       Date:  2019-04-04       Impact factor: 4.818

Review 3.  Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Authors:  Andreas Kronbichler; Moin A Saleem; Björn Meijers; Jae Il Shin
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

Review 4.  A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues.

Authors:  Takehiko Wada; Masaomi Nangaku
Journal:  Clin Kidney J       Date:  2015-09-15

5.  Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.

Authors:  Noboru Ichihara; Masatoshi Miyamura; Daichi Maeda; Tomohiro Fujisaka; Shu-Ichi Fujita; Hideaki Morita; Yoshihiro Takeda; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  J Arrhythm       Date:  2017-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.